Company CytRx Corporation Other OTC
Equities
CYTR
US2328286081
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 22-01-09 |
John Caloz
DFI | Director of Finance/CFO | 72 | 07-09-30 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Felix Kratz
PRN | Corporate Officer/Principal | - | 14-03-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 21-07-28 |
Cary Claiborne
BRD | Director/Board Member | 64 | 22-07-26 |
Joel Caldwell
BRD | Director/Board Member | 69 | 17-07-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 495,092 | 492,306 ( 99.44 %) | 0 | 99.44 % |
Company contact information
LadRx Corp.
11726 San Vicente Boulevard Suite 650
90049, Los Angeles
+310 826 5648
http://www.ladrxcorp.com![address CytRx Corporation(CYTR)](https://cdn.zonebourse.com/static/address/61175282.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |